CHAMPIONS ONCOLOGY, INC. Quarterly Debt-to-equity in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Champions Oncology, Inc. quarterly Debt-to-equity history and growth rate from Q4 2011 to Q3 2024.
  • Champions Oncology, Inc. Debt-to-equity for the quarter ending October 31, 2024 was -2.95K %, a 452% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -2.95K -3.79K -452% Oct 31, 2024
Q2 2024 -2.63K -3.13K -625% Jul 31, 2024
Q1 2024 -5.75K -6.13K -1643% Apr 30, 2024
Q4 2023 2.51K +2.19K +697% Jan 31, 2024
Q3 2023 839 +556 +197% Oct 31, 2023
Q2 2023 500 +226 +82% Jul 31, 2023
Q1 2023 373 +101 +37% Apr 30, 2023
Q4 2022 315 +47.2 +17.7% Jan 31, 2023
Q3 2022 283 +28.7 +11.3% Oct 31, 2022
Q2 2022 275 +18.5 +7.21% Jul 31, 2022
Q1 2022 272 +9.02 +3.43% Apr 30, 2022
Q4 2021 267 -2.2 -0.82% Jan 31, 2022
Q3 2021 254 -22.6 -8.16% Oct 31, 2021
Q2 2021 256 -54.4 -17.5% Jul 31, 2021
Q1 2021 263 -89.7 -25.4% Apr 30, 2021
Q4 2020 270 -117 -30.2% Jan 31, 2021
Q3 2020 277 -218 -44.1% Oct 31, 2020
Q2 2020 311 -148 -32.2% Jul 31, 2020
Q1 2020 353 -124 -26% Apr 30, 2020
Q4 2019 386 -26.7 -6.46% Jan 31, 2020
Q3 2019 495 -11.7 -2.32% Oct 31, 2019
Q2 2019 458 -185 -28.7% Jul 31, 2019
Q1 2019 477 -176 -26.9% Apr 30, 2019
Q4 2018 413 -1.32K -76.1% Jan 31, 2019
Q3 2018 507 -312 -38.1% Oct 31, 2018
Q2 2018 643 +237 +58.2% Jul 31, 2018
Q1 2018 653 +396 +154% Apr 30, 2018
Q4 2017 1.73K +1.49K +628% Jan 31, 2018
Q3 2017 819 +594 +265% Oct 31, 2017
Q2 2017 407 +217 +114% Jul 31, 2017
Q1 2017 257 +114 +79.7% Apr 30, 2017
Q4 2016 237 +157 +196% Jan 31, 2017
Q3 2016 225 +92.5 +70% Oct 31, 2016
Q2 2016 190 -62.2 -24.7% Jul 31, 2016
Q1 2016 143 -714 -83.3% Apr 30, 2016
Q4 2015 80.2 +1.05K Jan 31, 2016
Q3 2015 132 -220 -62.5% Oct 31, 2015
Q2 2015 252 +756 Jul 31, 2015
Q1 2015 856 +999 Apr 30, 2015
Q4 2014 -974 -900 -1215% Jan 31, 2015
Q3 2014 352 +398 Oct 31, 2014
Q2 2014 -503 -459 -1027% Jul 31, 2014
Q1 2014 -142 -96.3 -209% Apr 30, 2014
Q4 2013 -74.1 -20.8 -39.1% Jan 31, 2014
Q3 2013 -46.2 +19.3 +29.4% Oct 31, 2013
Q2 2013 -44.7 +44.5 +49.9% Jul 31, 2013
Q1 2013 -46 +94.1 +67.1% Apr 30, 2013
Q4 2012 -53.3 +203 +79.2% Jan 31, 2013
Q3 2012 -65.5 Oct 31, 2012
Q2 2012 -89.2 Jul 31, 2012
Q1 2012 -140 Apr 30, 2012
Q4 2011 -257 Jan 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.